Christopher J. Packard

15.0k total citations · 4 hit papers
92 papers, 11.5k citations indexed

About

Christopher J. Packard is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Christopher J. Packard has authored 92 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Surgery, 53 papers in Endocrinology, Diabetes and Metabolism and 24 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Christopher J. Packard's work include Lipoproteins and Cardiovascular Health (60 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (45 papers) and Cancer, Lipids, and Metabolism (21 papers). Christopher J. Packard is often cited by papers focused on Lipoproteins and Cardiovascular Health (60 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (45 papers) and Cancer, Lipids, and Metabolism (21 papers). Christopher J. Packard collaborates with scholars based in United Kingdom, United States and Netherlands. Christopher J. Packard's co-authors include James Shepherd, Ian Ford, Stuart M. Cobbe, A R Lorimer, Peter W. Macfarlane, Christopher Isles, James H. McKillop, Muriel Caslake, Dilys J. Freeman and Antonio M. Gotto and has published in prestigious journals such as Nature, New England Journal of Medicine and Nucleic Acids Research.

In The Last Decade

Christopher J. Packard

92 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 5.8k citations James Shepherd, Ian Ford et al. profile →
Pravastatin and the Development of Diabetes Mellitus

2001 667 citations Dilys J. Freeman, Naveed Sattar et al. profile →
Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1994 457 citations Bruce A. Griffin, Dilys J. Freeman et al. Atherosclerosis profile →
Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-I

1978 387 citations James Shepherd, Christopher J. Packard et al. profile →

Peers

Countries citing papers authored by Christopher J. Packard

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Packard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Packard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Packard more than expected).

Fields of papers citing papers by Christopher J. Packard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Packard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Packard. The network helps show where Christopher J. Packard may publish in the future.

Co-authorship network of co-authors of Christopher J. Packard

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Packard. A scholar is included among the top collaborators of Christopher J. Packard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Packard. Christopher J. Packard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) 2012 ·PLoS ONE ·Rosalinde K. E. Poortvliet, Ian Ford, Suzanne M. Lloyd, Naveed Sattar, Simon P. Mooijaart, Anton J.M. de Craen, Rudi G. J. Westendorp, J. Wouter Jukema, Christopher J. Packard, Jacobijn Gussekloo, Wouter de Ruijter, David J. Stott	61
2	KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly 2011 ·Atherosclerosis ·(unknown), Eliana Polisecki, Kouji Kajinami, Stella Trompet, Michele Robertson, Ian Ford, J. Wouter Jukema, Anton J.M. de Craen, Rudi G. J. Westendorp, James Shepherd, Christopher J. Packard, Brendan M. Buckley, Ernst J. Schaefer	27
3	Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly 2009 ·Journal of Lipid Research ·Eliana Polisecki, Inga Peter, Jason S. Simon, Robert A. Hegele, Michele Robertson, Ian Ford, James Shepherd, Christopher J. Packard, J. Wouter Jukema, Anton J.M. de Craen, Rudi G. J. Westendorp, Brendan M. Buckley, Ernst J. Schaefer	49
4	Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria 2008 ·Atherosclerosis ·Samira Bell, Josephine Cooney, Christopher J. Packard, Muriel Caslake, Christopher J. Deighan	3
5	Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study 2008 ·American Journal of Clinical Nutrition ·Muriel Caslake, Elizabeth A. Miles, Barbara Kofler, Georg Lietz, Peter J. Curtis, Christopher K. Armah, Alan Kimber, J. Grew, Lesley Farrell, (unknown), (unknown), Aleix Sala‐Vila, Annette L. West, John C. Mathers, Christopher J. Packard, Christine M. Williams, Philip C. Calder, Anne Marie Minihane	133
6	Familial hypobetalipoproteinemia due to a novel early stop mutation 2008 ·Journal of clinical lipidology ·Paul N. Durrington, Valentine Charlton-Menys, Christopher J. Packard, Muriel Caslake, Jian Wang, Deepak Bhatnagar, J. E. Scott, Robert A. Hegele	3
7	Fractionation of cholesteryl ester rich intermediate density lipoprotein subpopulations by chondroitin sulphate 2007 ·Atherosclerosis ·Barbara J. Meyer, Laurence Duvillard, Alice Owen, Christopher J. Packard, Muriel Caslake	6
8	Goals of statin therapy: Three viewpoints 2002 ·Current Atherosclerosis Reports ·Gilbert R. Thompson, Christopher J. Packard, Neil J. Stone	4
9	Patients with nephrotic-range proteinuria have apolipoprotein C and E deficient VLDL1 2000 ·Kidney International ·Christopher J. Deighan, Muriel Caslake, Michael V. McConnell, J. M. Boulton‐Jones, Christopher J. Packard	21
10	Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation 2000 ·American Journal of Kidney Diseases ·Christopher J. Deighan, Muriel Caslake, Michael V. McConnell, J. M. Boulton‐Jones, Christopher J. Packard	106
11	Atherogenic lipoprotein phenotype in Type 2 diabetes: reversal with micronised fenofibrate 1999 ·Diabetes/Metabolism Research and Reviews ·Michael Feher, Muriel Caslake, (unknown), Alison J. Cox, Christopher J. Packard	55
12	Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects 1999 ·Atherosclerosis ·Raija Malmström, Christopher J. Packard, Muriel Caslake, Dorothy Bedford, Philip Stewart, James Shepherd, Marja‐Riitta Taskinen	24
13	Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance 1995 ·Atherosclerosis ·K. C. B. Tan, Michael B. Cooper, Kun Ling, Bruce A. Griffin, Dilys J. Freeman, Christopher J. Packard, James Shepherd, C. N. Hales, D. J. Betteridge	94
14	Current concepts in the treatment of familial hypercholesterolaemia 1995 ·Current Opinion in Lipidology ·Christopher J. Packard, James Shepherd	8
15	The ins/del polymorphism in the signal sequence of apolipoprotein B has no effect on lipid parameters 1993 ·Clinica Chimica Acta ·Dairena Gaffney, Dilys J. Freeman, James Shepherd, Christopher J. Packard	18
16	Restriction fragment length polymorphisms in the Apo B gene in relation to coronary heart disease in a Southern Asian population 1991 ·Clinica Chimica Acta ·Shanthi Mendis, James Shepherd, Christopher J. Packard, Dairena Gaffney	16
17	Genetic variation in the cholesteryl ester transfer protein and apolipoprotein A-I genes and its relation to coronary heart disease in a Sri Lankan population 1990 ·Atherosclerosis ·Shanthi Mendis, James Shepherd, Christopher J. Packard, Dairena Gaffney	36
18	Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation 1990 ·Atherosclerosis ·Bruce A. Griffin, Muriel Caslake, Brigitte Yip, Graeme W. Tait, Christopher J. Packard, James Shepherd	198
19	Low-density lipoprotein metabolism in the nephrotic syndrome 1990 ·Metabolism ·Graham Warwick, Muriel Caslake, J. M. Boulton‐Jones, (unknown), Christopher J. Packard, James Shepherd	68
20	An StuI RFLP at the human cholesteryl ester transfer protein (CETP) locus 1989 ·Nucleic Acids Research ·Dilys J. Freeman, James Shepherd, Christopher J. Packard, Steve E. Humphries, Dairena Gaffney	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact